Log In
Print
BCIQ
Print
Print this Print this
 

MIN-301 (formerly NRG-101)

  Manage Alerts
Collapse Summary General Information
Company Minerva Neurosciences Inc.
DescriptionNeuregulin 1 (NRG1) peptide
Molecular Target Neuregulin 1 (NRG1)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today